The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000-2006

Clinical Microbiology and Infection

Volumn 14, Issue 7, 2008, Pages 670-676

  Otter, J A ^a   French, Gary L ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Ciprofloxacin; Community associated MRSA; Fluoroquinolones; Phenotypic marker; Spa typing

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; METICILLIN; NEOMYCIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL FEATURE; COMMUNICABLE DISEASE; CONTROLLED STUDY; GENE CASSETTE; GENETIC HETEROGENEITY; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OUTPATIENT DEPARTMENT; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS INFECTION; TEACHING HOSPITAL; UNITED KINGDOM;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 45249102461     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02017.x     Document Type: Article

References (40)

1. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874-885.
2. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: An emerging threat. Lancet Infect Dis 2005; 5: 275-286.
3. Labandeira-Rey M, Couzon F, Boisset S et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315: 1130-1133.
4. Robinson DA, Kearns AM, Holmes A et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 2005; 365: 1256-1258.
5. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003; 9: 978-984.
6. Naimi TS, LeDell KH, Como-Sabetti K et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290: 2976-2984.
7. Okuma K, Iwakawa K, Turnidge JD et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40: 4289-4294.
8. Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: Frequency, characterization, and association with clinical disease. J Clin Microbiol 2005; 43: 2384-2390.
9. Otter JA, Klein JL, Watts TL, Kearns AM, French GL. Identification and control of an outbreak of ciprofloxacin-susceptible EMRSA-15 on a neonatal unit. J Hosp Infect 2007; 67: 232-239.
10. Coombs GW, Pearson JC, O'Brien FG, Murray RJ, Grubb WB, Christiansen KJ. Methicillin-resistant Staphylococcus aureus clones, Western Australia. Emerg Infect Dis 2006; 12: 241-247.
11. David MD, Kearns AM, Gossain S, Ganner M, Holmes A. Community-associated meticillin-resistant Staphylococcus aureus: Nosocomial transmission in a neonatal unit. J Hosp Infect 2006; 64: 244-250.
12. Otter JA, French GL. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: An emerging threat. Lancet Infect Dis 2006; 6: 753-755.
13. Ellington MJ, Hope R, Ganner M et al. Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK? J Antimicrob Chemother 2007; 60: 402-405.
14. Rossney AS, Shore AC, Morgan PM, Fitzgibbon MM, O'Connell B, Coleman DC. The emergence and importation of diverse genotypes of MRSA harboring the Panton-Valentine leukocidin gene pvl reveals that pvl is a poor marker for community-acquired MRSA in Ireland. J Clin Microbiol 2007; 45: 2554-2563.
15. Boyle-Vavra S, Ereshefsky B, Wang CC, Daum RS. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal Chromosome Cassette mec (SCC mec) Type.VT or SCCmec Type.IV. J Clin Microbiol 2005; 43: 4719-4730.
16. Tacconelli E, Venkataraman L, De Girolami PC, D'Agata E. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: Distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother 2004; 53: 474-479.
17. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993; 25: 97-108.
18. Herold BC, Immergluck LC, Maranan MC et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-598.
19. Tristan A, Bes M, Meugnier H et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13: 594-600.
20. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-674.
21. Kaplan SL, Hulten KG, Gonzalez BE et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40: 1785-1791.
22. Wannet WJB, Spalburg E, Heck MEOC et al. Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton-Valentine leucocidin genes in the Netherlands. J Clin Microbiol 2005; 43: 3341-3345.
23. Health Protection Agency. Community MRSA in England and Wales: definition through strain characterisation. CDR Wkly 2005; 15: 11.
24. Jeyaratnam D, Reid C, Kearns A, Klein J. Community associated MRSA: An alert to paediatricians. Arch Dis Child 2006; 91: 511-512.
25. Johnson AP, Aucken HM, Cavendish S et al. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: Analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother 2001; 48: 143-144.
26. Health Protection Agency. Hospital-associated transmission of Panton-Valentine Leukocidin (PVL) positive community-associated MRSA in the West Midlands. CDR Wkly 2006; 16: 50.
27. Jeyaratnam D, Edgeworth JD, French GL. Enhanced surveillance of meticillin-resistant Staphylococcus aureus bacteraemia in a London teaching hospital. J Hosp Infect 2006; 63: 365-373.
28. Brown DFJ, Edwards DI, Hawkey PM et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 2005; 56: 1000-1018.
29. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 2155-2161.
30. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-1132.
31. Harmsen D, Claus H, Witte W et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41: 5442-5448.
32. Strommenger B, Kettlitz C, Weniger T, Harmsen D, Friedrich AW, Witte W. Assignment of Staphylococcus isolates to groups by spa typing, SmaI macrorestriction analysis, and multilocus sequence typing. J Clin Microbiol 2006; 44: 2533-2540.
33. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-1015.
34. Loughrey A, Millar BC, Goldsmith CE, Rooney PJ, Moore JE. Emergence of community-associated MRSA (CA-MRSA) in Northern Ireland. Ulster Med J 2007; 76: 68-71.
35. Adedeji A, Weller TM, Gray JW. MRSA in children presenting to hospitals in Birmingham, UK. J Hosp Infect 2007; 65: 29-34.
36. Schneider-Lindner V, Delaney JA, Dial S, Dascal A, Suissa S. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis 2007; 13: 994-1000.
37. Voyich JM, Otto M, Mathema B et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194: 1761-1770.
38. Tenover FC, McDougal LK, Goering RV et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 2006; 44: 108-118.
39. Hota B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein RA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: Do public housing and incarceration amplify transmission? Arch Intern Med 2007; 167: 1026-1033.
40. Kearns AM, Rathman IR, Holmes A, Pitt TL, Cookson BD. An unusual clone of MRSA causing infection in injecting drug users. J Infect 2004; 49: 49-50.